Vera Therapeutics (NASDAQ: VERA) net income
Vera Therapeutics reported a net loss of $299.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $152.1m. Earnings per share were −$4.66.
Vera Therapeutics's best year of the last 6 was fiscal 2021. It reported a loss in 6 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$299.6m | — | — | −$4.66 |
| 2024 | −$152.1m | — | — | −$2.75 |
| 2023 | −$96.0m | — | — | −$2.25 |
| 2022 | −$89.1m | — | — | −$3.35 |
| 2021 | −$32.6m | — | — | −$2.43 |
| 2020 | −$53.4m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Vera Therapeutics net income compared with its sector
By net income for its latest fiscal year, Vera Therapeutics ranks 447th of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 445th | Madrigal Pharmaceuticals | −$288.3m | −30.1% |
| 446th | Minerva Neurosciences | −$293.4m | — |
| 447th | Vera Therapeutics | −$299.6m | — |
| 448th | Roivant Sciences | −$299.8m | −3,629.2% |
| 449th | Praxis Precision Medicines | −$303.3m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Vera Therapeutics
- How much did Vera Therapeutics earn in fiscal 2025?
- Vera Therapeutics reported a net loss of $299.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $152.1m.
- What are the earnings per share of Vera Therapeutics?
- They were −$4.66 in fiscal 2025, compared with −$2.75 in fiscal 2024.
- Where does Vera Therapeutics rank in its sector by net income?
- It ranks 447th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Vera Therapeutics come from?
- From the annual report (Form 10-K) that Vera Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Vera Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Vera Therapeutics: the Vera Therapeutics page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.